GLP-1 questions: alcohol, hair loss, “Ozempic face” and how long
Made with AI tools and overseen by an Australian GP · Updated 8 November 2026
The questions people actually type into search bars, answered with trial data instead of TikTok.
Quick answer: There’s no direct interaction with alcohol, but it can worsen nausea and reflux, and many people find they want less. Hair loss is a listed side effect (3–5% vs 1% on placebo). “Ozempic face” is facial fat loss from fast weight loss, not a drug effect. Most people need to keep taking it to keep the weight off.
Alcohol
- No direct drug interaction is described, but alcohol can make nausea and reflux worse.
- With diabetes, alcohol plus insulin or a sulfonylurea raises the risk of low blood sugar.
- Both alcohol and GLP-1 medicines are linked to pancreatitis. If you’ve had pancreatitis, ask your doctor about avoiding alcohol.
- Many people report less interest in alcohol. In a small 9-week trial of 48 adults with alcohol use disorder, semaglutide reduced drinks per drinking day and craving. Larger trials are needed, and it isn’t approved for this.
Hair loss
- Listed as a side effect: 3% on semaglutide 2.4 mg and 4–5% on tirzepatide, versus 1% on placebo.
- If it worries you, see your GP. Iron, thyroid and other causes can be checked. See hair loss.
“Ozempic face”
- Not a medical term. It describes loss of facial fat and fullness after fast weight loss from any cause, including surgery.
- It isn’t a direct drug effect and isn’t harmful. Slower weight loss, enough protein, sun protection and good skin care may help.
How long to take it
- Weight loss builds over about 68–72 weeks in the main trials.
- Weight usually returns after stopping. See stopping and weight regain.
- How long to continue is a decision for you and your doctor, weighing benefits, side effects and cost.
When it doesn’t work as hoped
- Results vary. In STEP 1, 86% of people on semaglutide lost at least 5% of their weight, so about 1 in 7 didn’t.
- In SURMOUNT-1, 85–91% on tirzepatide lost at least 5%, depending on dose.
- If you’re not responding, your doctor can review the dose, other medicines and other options.
Get urgent help (000 in Australia, or your local emergency number) for severe tummy pain that won’t settle, with or without vomiting, or swelling of the face or throat. See a doctor the same day if you can’t keep fluids down, have pain under the right ribs with fever or yellow skin, or notice sudden changes in your vision.
Need a brain break? Play Dxtective, the daily diagnosis puzzle, or browse all medical games. Free, no sign-up.
Common questions
Can I drink alcohol on Ozempic or Mounjaro?
There’s no direct interaction described, but alcohol can worsen nausea and reflux, and with insulin or a sulfonylurea it raises the risk of low blood sugar. Many people find they want less.
Does Ozempic cause hair loss?
It’s a listed side effect but uncommon: 3% on semaglutide 2.4 mg versus 1% on placebo in the trials, and 4–5% on tirzepatide.
Is “Ozempic face” permanent?
Facial fat loss tends to stay if the weight stays off. It isn’t harmful, and slower weight loss may make it less noticeable.
How long do I need to take a GLP-1 medicine?
The benefits last only while you take it, and most people regain weight after stopping. How long to continue is a decision for you and your doctor.
What if a GLP-1 medicine doesn’t work for me?
Some people lose much less than average. About 1 in 7 people on semaglutide in STEP 1 lost less than 5% of their weight. Your doctor can review your treatment and other options.
Evidence and more information
- Mozaffarian et al, 2025: Nutritional priorities to support GLP-1 therapy for obesity (joint advisory of four US obesity and nutrition societies)
- Drugs.com: Drinking alcohol on Ozempic, what are the risks?
- Epocrates: Hendershot et al, JAMA Psychiatry 2025, semaglutide in alcohol use disorder
- US FDA prescribing information for Wegovy (semaglutide), February 2026: side-effect table, warnings
- US prescribing information for Zepbound (tirzepatide): side-effect table, gallbladder and pancreatitis rates
- Cleveland Clinic: What is “Ozempic face”?
- Wilding et al, NEJM 2021: STEP 1, semaglutide 2.4 mg for weight management (weight loss, side-effect and gallbladder rates)
maladywise.com/glp-1/faq/